Leap Therapeutics (LPTX) Misses Q3 EPS by 44c

Leap Therapeutics (NASDAQ: LPTX) reported Q3 EPS of ($0.44).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• MARA amends Texas power site purchase agreement, posts $100M deposit
• Netcapital gets second Nasdaq notice over late financial filings